Healthcare provider profile · identity verified

Lauri B. Conroy, M.D.

Internal Medicine · EAST CHINA, MI · NPI 1023010360

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	483	148
Levothyroxine Sodium	Levothyroxine Sodium	306	82
Omeprazole	Omeprazole	275	88
Metoprolol Succinate	Metoprolol Succinate	269	81
Enalapril Maleate	Enalapril Maleate	219	67
Amlodipine Besylate	Amlodipine Besylate	205	60
Alendronate Sodium	Alendronate Sodium	203	63
Simvastatin	Simvastatin	195	52
Rosuvastatin Calcium	Rosuvastatin Calcium	188	56
Metformin Hcl	Metformin Hcl	159	52
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	150	59
Lisinopril	Lisinopril	143	43
Losartan Potassium	Losartan Potassium	124	39
Venlafaxine Hcl Er	Venlafaxine Hcl	123	29
Metoprolol Tartrate	Metoprolol Tartrate	112	35
Fluoxetine Hcl	Fluoxetine Hcl	109	40
Trazodone Hcl	Trazodone Hcl	106	38
Ozempic	Semaglutide	104	22
Tamsulosin Hcl	Tamsulosin Hcl	97	28
Ibuprofen	Ibuprofen	96	36
Sertraline Hcl	Sertraline Hcl	94	30
Alprazolam	Alprazolam	92	22
Albuterol Sulfate Hfa	Albuterol Sulfate	91	43
Furosemide	Furosemide	85	28
Hydralazine Hcl	Hydralazine Hcl	83	23
Buspirone Hcl	Buspirone Hcl	75	22
Mounjaro	Tirzepatide	70	14
Fluticasone Propionate	Fluticasone Propionate	67	29
Hydrochlorothiazide	Hydrochlorothiazide	65	21
Pantoprazole Sodium	Pantoprazole Sodium	64	16
Quetiapine Fumarate	Quetiapine Fumarate	60	15
Potassium Chloride	Potassium Chloride	58	18
Oxybutynin Chloride Er	Oxybutynin Chloride	55	15
Glipizide Er	Glipizide	54	14
Pioglitazone Hcl	Pioglitazone Hcl	54	18
Escitalopram Oxalate	Escitalopram Oxalate	52	20
Fenofibrate	Fenofibrate	52	15
Atenolol	Atenolol	50	16
Gabapentin	Gabapentin	49	24
Pravastatin Sodium	Pravastatin Sodium	48	16
Duloxetine Hcl	Duloxetine Hcl	47	15
Eliquis	Apixaban	45	suppressed
Meloxicam	Meloxicam	43	13
Donepezil Hcl	Donepezil Hcl	42	12
Montelukast Sodium	Montelukast Sodium	41	14
Tramadol Hcl	Tramadol Hcl	41	13
Methocarbamol	Methocarbamol	39	23
Baclofen	Baclofen	38	11
Ezetimibe	Ezetimibe	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	suppressed
Diazepam	Diazepam	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Bupropion Hcl	Bupropion Hcl	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	12
Zolpidem Tartrate	Zolpidem Tartrate	31	15
Bupropion Xl	Bupropion Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Famotidine	Famotidine	29	13
Prednisone	Prednisone	29	27
Allopurinol	Allopurinol	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Estradiol	Estradiol	27	16
Nifedipine Er	Nifedipine	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	23
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Clotrimazole	Clotrimazole	22	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Bydureon Bcise	Exenatide Microspheres	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Cefuroxime	Cefuroxime Axetil	17	14
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Fluconazole	Fluconazole	16	15
Lamotrigine	Lamotrigine	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Lovastatin	Lovastatin	15	suppressed
Methylprednisolone	Methylprednisolone	15	15
Warfarin Sodium	Warfarin Sodium	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Azithromycin	Azithromycin	13	11
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Finasteride	Finasteride	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Temazepam	Temazepam	12	suppressed
Vraylar	Cariprazine Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error